Mark Duggan

The Trione Director of the Stanford Institute for Economic Policy Research at Stanford University

Mark Duggan is a prominent economist and professor at Stanford University. He held the position of Trione Director of the Stanford Institute for Economic Policy Research (SIEPR) from September 1, 2015 to August 31, 2024.2 Currently, he serves as the Wayne and Jodi Cooperman Professor of Economics at Stanford.1 2 3

Academic Background and Career

Mark Duggan received his B.S. and M.S. in Electrical Engineering from MIT in 1992 and 1994, respectively, and his Ph.D. in Economics from Harvard University in 1999.4 His academic career has included positions at:

University of Chicago (1999-2003)
University of Maryland (2003-2011)
Wharton School, University of Pennsylvania (2011-2014)
Stanford University (2014-present)4 6

Research Focus and Achievements

Duggan's research primarily concentrates on:

Health care sector
Government expenditure programs (Medicare, Medicaid, Social Security)
Effects of federal disability programs on the labor market
Impact of the Affordable Care Act1 3

His work has been published in leading academic journals and featured in prominent media outlets such as The Economist, The New York Times, and The Wall Street Journal.1 2

Notable achievements include:

Recipient of the 2010 ASHEcon Medal (awarded to the leading health economist in the U.S. under age 40)1 2
Co-recipient of the National Institute for Health Care Management's 2011 Health Care Research Award6

Professional Roles and Service

Senior Economist for Health Care Policy at the White House Council of Economic Advisers (2009-2010)1 2
Co-Editor of the American Economic Journal: Economic Policy and the Journal of Public Economics6
Research Associate at the National Bureau of Economic Research6
Expert witness for the U.S. Department of Justice6

Teaching and Mentorship

At Stanford, Duggan teaches "Econ 1" and advises numerous undergraduate and graduate students.1 2 He has received several awards for his teaching.5

Mark Duggan's extensive experience in academia, policy research, and government advisory roles has established him as a leading figure in the field of health economics and public policy.